Kessler JH - Search Results

1

Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.

Griffioen M, Kessler JH, Borghi M, van Soest RA, van der Minne CE, Nouta J, van der Burg SH, Medema JP, Schrier PI, Falkenburg JH, Osanto S, Melief CJ. Griffioen M, et al. Among authors: kessler jh. Clin Cancer Res. 2006 May 15;12(10):3130-6. doi: 10.1158/1078-0432.CCR-05-2578. Clin Cancer Res. 2006. PMID: 16707612

2

Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.

Kessler JH, Mommaas B, Mutis T, Huijbers I, Vissers D, Benckhuijsen WE, Schreuder GM, Offringa R, Goulmy E, Melief CJ, van der Burg SH, Drijfhout JW. Kessler JH, et al. Hum Immunol. 2003 Feb;64(2):245-55. doi: 10.1016/s0198-8859(02)00787-5. Hum Immunol. 2003. PMID: 12559627

3

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance.

Melief CJM, Kessler JH. Melief CJM, et al. Among authors: kessler jh. Genome Med. 2017 May 24;9(1):44. doi: 10.1186/s13073-017-0439-8. Genome Med. 2017. PMID: 28539110 Free PMC article. Review.

4

BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.

Kessler JH, Bres-Vloemans SA, van Veelen PA, de Ru A, Huijbers IJ, Camps M, Mulder A, Offringa R, Drijfhout JW, Leeksma OC, Ossendorp F, Melief CJ. Kessler JH, et al. Leukemia. 2006 Oct;20(10):1738-50. doi: 10.1038/sj.leu.2404354. Epub 2006 Aug 24. Leukemia. 2006. PMID: 16932347

5

Identification of T-cell epitopes for cancer immunotherapy.

Kessler JH, Melief CJ. Kessler JH, et al. Leukemia. 2007 Sep;21(9):1859-74. doi: 10.1038/sj.leu.2404787. Epub 2007 Jul 5. Leukemia. 2007. PMID: 17611570 Review.

6

Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types.

Kessler JH, Mullauer FB, de Roo GM, Medema JP. Kessler JH, et al. Cancer Lett. 2007 Jun 18;251(1):132-45. doi: 10.1016/j.canlet.2006.11.003. Epub 2006 Dec 13. Cancer Lett. 2007. PMID: 17169485

7

Competition-based cellular peptide binding assay for HLA class I.

Kessler JH, Benckhuijsen WE, Mutis T, Melief CJ, van der Burg SH, Drijfhout JW. Kessler JH, et al. Curr Protoc Immunol. 2004 Sep;Chapter 18:Unit 18.12. doi: 10.1002/0471142735.im1812s61. Curr Protoc Immunol. 2004. PMID: 18432926 Review.

8

Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

Kessler JH, Beekman NJ, Bres-Vloemans SA, Verdijk P, van Veelen PA, Kloosterman-Joosten AM, Vissers DC, ten Bosch GJ, Kester MG, Sijts A, Wouter Drijfhout J, Ossendorp F, Offringa R, Melief CJ. Kessler JH, et al. J Exp Med. 2001 Jan 1;193(1):73-88. doi: 10.1084/jem.193.1.73. J Exp Med. 2001. PMID: 11136822 Free PMC article.

9

Betulinic acid, a natural compound with potent anticancer effects.

Mullauer FB, Kessler JH, Medema JP. Mullauer FB, et al. Among authors: kessler jh. Anticancer Drugs. 2010 Mar;21(3):215-27. doi: 10.1097/CAD.0b013e3283357c62. Anticancer Drugs. 2010. PMID: 20075711 Review.

10

Betulinic Acid Kills Colon Cancer Stem Cells.

Potze L, di Franco S, Kessler JH, Stassi G, Medema JP. Potze L, et al. Among authors: kessler jh. Curr Stem Cell Res Ther. 2016;11(5):427-33. doi: 10.2174/1574888x11666151203223512. Curr Stem Cell Res Ther. 2016. PMID: 26647913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page